Lincoln Pharmaceuticals Limited has received European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj (Gujarat). The certification will allow the company to market its products in all the 27 member countries of EU and also give an access to European Economic Area (EEA) countries. The company aims to enter EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.

Fabric manufacturer, Raymond Ltd, announced that the company is planning to raise funds via NCDs this week.

Pharma major Lupin Limited announced that it had launched an authorised generic version of Bausch Health’s Apriso (Mesalamine extended-release capsules 0.375 gm) in US Market.

Alembic Pharmaceuticals Limited informed the bourses on Tuesday that its joint venture, Aleor Dermaceuticals Limited has received approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Clobetasol Propionate shampoo, 0.05 per cent.

The market opened in the green on May 19, 2020. The previous trading session witnessed the Sensex down  by 1,068.75 points to end at 30,028.98 and the Nifty was down 313.60 points to close at 8,823.25.

Everyone is eager to know what the mutual fund managers bought or sold and especially keen to know what they actually bought. So, here, we bring you a list of stocks that attracted the fund managers in the month of April 2020. Let’s find out.

The market opened in the green on May 19, 2020. The previous trading session witnessed the Sensex down  by 1,068.75 points to end at 30,028.98 and the Nifty was down 313.60 points to close at 8,823.25.

The market opened in the green on May 19, 2020, overall volumes in futures & options currently stand at 1,81 crore contracts with a turnover of Rs. 9,03,860.84 crore.

The market opened in the green on May 19, 2020, overall volumes in futures & options currently stand at 1,81 crore contracts with a turnover of Rs. 9,03,860.84 crore.

Laurus Labs today informed the bourses that it has received an approval from USFDA under President’s Emergency Plan for AIDS Relief (PEPFAR) for two abbreviated new drug applications (ANDAs)